Early stage researcher projects
// ESR1
Development of mass spectrometric methods combined with chemometrics in a non-target approach for identification of hitherto unknown PFASs.
// ESR2
Development of a robust and high-throughput approach for screening consumer products.
// ESR3
Determining the release of legacy, alternative and unknown PFASs to the atmosphere and consequences for near- and far-field human exposure.
// ESR4
Development of analytical methods for determination of new known (e.g. PFECA, PFESA, HFPO-dimer and trimer acids, polyfluorinated acids) and unknown PFASs.
// ESR5
Using in vitro human skin equivalent models to characterize the trans-dermal uptake of PFASs from both indoor dust and source materials .
// ESR6
Investigating the impact of legacy and emerging PFAS, as well as human-relevant PFAS mixtures on cholesterol homeostasis and cholesterol synthesis and metabolism.
// ESR7
Development of cell- and organ-on-chip-based metabolomic and lipidomic approaches using human adrenal cortex.
// ESR8
Development and application of methods for assessing legacy and alternative PFASs using the total oxidizable precirsr method in addition to total fluorine concentrations in human plasma.
// ESR9
Assessment of the effects of legacy and replacement PFAS exposure on gene expression and diabetes.
// ESR10
To identify associations between available PFAS concentration data in human serum and corresponding serum lipids and metabolomics data.
// ESR11
Evaluation of innovative treatment techniques for the decomposition and removal of PFASs in stormwater, groundwater, wastewater and landfill leachate.
// ESR12
Development of an innovative technique for in-situ remediation of PFASs contaminated groundwater.
// ESR13
Determining the fate and transport behaviour of PFAS in diverse natural unsaturated soils with and without sorbent amendments.
// ESR14
Biodegradation assays of newly synthesized PFASs and potential PFASs precursors in closed bottle systems, analysis of degradation products.
// ESR15
Determine if fluorinated and non-fluorinated alternatives are safer, more sustainable alternatives to long-chain PFASs in selected consumer products and to propose options for the assessment, regulation and management of alternative PFASs where necessary.
